Hospital Unviersitario Miguel Servet — Clinical Trial Site

356 Registered trials

127 Currently recruiting

Organisation

Hospital Unviersitario Miguel Servet

Location

Zaragoza, Spain

Identifier

ORG-100041170

Address

Paseo De Isabel La Catolica 1-3, 50009, Spain

Departments

#2105:Oftalmología
#2500: Servicio de oncología
#3436: Unidad Lipidos
#4207:Servicio Medicina Interna
#ES10008:Gastroenterology
203: Ophthalmology
2105: Oftalmología
2105:Oftalmología
2105:Oftalmología Infantil
3108: medicina interna
34006: Oncología
3605; Oncología
4207: Lipidólogos (Lab de Inv. Molecular)
472: Oftalmología Infantil
7003: Oncología
7240034:Oftalmología
724008: Oftalmología
805: Ensayos clínicos. Oncología médica
Aparato Digestivo
Cardiología
Cardiology
Departamento de Medicina, Psiquiatría y Dermatología
Department of Neurology
Department of oncology
Department of Translatio
Dermatologia
Dermatologist
Dermatology
Dermatology department
Digestive
Digestive department
Digestive system
Digestive System Service
Digestivo
Digestivo Hepatologia
Endocrinología
Endocrinology
ESP013: Oncología Médica
Gastroenterology
Gastroenterology & Hepatology Service
Gastroenterology Department
Haemostasis
Hematología
Hematología y Hemoterapia
Hematology
Hematology and Hemotherapy Department
Hemostasis and Thrombosis
Hepatology
Hepatology Department
hospital universitario miguel servet
Hospital Universitario Miguel Servet( #1)
Internal medicine
Lipidology
Medical Oncology
Medical Oncology Department
Medical Oncology service
Medicina/Respiratorio
Medicine
n/a
NA
Nefrología
Nefrology
Neonatology
Nephrology
Neumología
Neumology
Neurología
Neurology
Oftalmologia
ONCOLGIA
Oncología
Oncología Médica
Oncology
Oncology department
Oncology service
Ophtalmology
Ophthalmology
Ophthalmology service
Paediatric Oncology Department
Pediatria
Pediatric
Pediatric endocrinology
Pediatric oncohematology
Pediatric Oncology
Pediatric Oncology and Hematology
Pediatric oncology department
Pediatrics
Pediatry
Pneumology
Pulmonology
Radiation Oncology
Respiratory Department
Respiratory medicine
Servicio de digestivo
Servicio de Aparato Digestivo, Unidad de Enfermedad Inflamatoria Intestinal
Servicio de Dermatología
Servicio de Digestivo
Servicio de Gastroenterología
Servicio de Hematologia
Servicio de hematologia y hemoterapia
Servicio de Medicina Interna
Servicio de Nefrologia
Servicio de Neumología
Servicio de Oftalmologia
Servicio de Oncología
Servicio de Oncologia Medica
Servicio de Oncología y Hematología Pediátricas
Servicio Gastroenterologia
Servicio Oncología
Stroke Unit
Surgery
UC-1593042: Oftalmología
Unidad de Lípidos
Unidad Investigación Translacional (UIT).

Clinical trials at this site (356)

Search interface

A Phase 2, Open-Label, Multicenter, Cohort Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab in Patien… Ended

2024-513229-22-00 Advanced cutaneous melanoma and Advanced mucosal melano 4 2022-04-21
Brightline-1: A study to compare brigimadlin (BI 907828) with doxorubicin in people with a type of cancer called dedifferentiated liposarcom… Ended

2024-511361-11-00 Advanced dedifferentiated liposarcoma 10 2022-03-25
Study Comparing Bemarituzumab plus Chemotherapy with Placebo and Chemotherapy in Previously Untreated Advanced Gastric or Gastroesophageal J… Ended

2023-505457-40-00 Previously Untreated Advanced Gastric or Gastroesophage 5 2022-02-02
A Study of Evorpacept (ALX148) in Patients with Advanced Gastric Cancer Ended

2023-509406-30-00 Patients with HER2-overexpressing advanced or metastati 10 2022-01-24
Study to assess efficacy, safety, and tolerability of Tozorakimab in patients with symptomatic chronic obstructive pulmonary disease (COPD) … Ended

2023-503571-19-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2022-01-20
CO-THEIA (COMBINATION THERAPY WITH METHOTREXATE AND ADALIMUMAB FOR UVEITIS): EFFICACY, SAFETY AND COST-EFFECTIVENESS OF METHOTREXATE, ADALIM… Ended

2024-513123-17-00 Non-infection uveitis 5 2022-01-12
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Oc… Ended

2022-502542-28-00 Sickle Cell Disease 4 2021-12-06
Phase II Study of efti plus pembrolizumab combination therapy for head and neck cancer (HNSCC). Ended

2024-510762-16-00 Metastatic head and neck squamous cell carcinoma (HNSCC 4 2021-11-30
The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic… Ended

2024-517251-12-00 Recurrent or metastatic head and neck squamous cell car 5 2021-11-02
SURVIVAL ANALYSIS AFTER NEOADJUVANT TREATMENT IN RESECTABLE PANCREATIC CANCER WITH RISK FACTORS Ended

2024-519633-35-00 Resectable pancreatic adenocarcinoma with risk factors 6 2021-10-25
Study to Evaluate the Long-Term Efficacy and Safety of the Investigational Drug LIB003 for the Reduction of Cholesterol in Patients with Hom… Ended

2023-510057-41-00 Patients With Homozygous and Heterozygous Familial Hype 5 2021-10-06
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease … Ended

2023-506926-35-00 Atherosclerotic cardiovascular disease, chronic kidney 5 2021-09-24
Study to Evaluate the Safety and Efficacy of Treatment with NLM-001 before Standard Chemotherapy plus Zalifrelimab in Patients with Advanced… Ended

2024-518852-22-00 Advanced Pancreatic Cancer 3 2021-09-03
A clinical study of OPT-302 with aflibercept compared to aflibercept alone in patients with neovascular age-related macular degeneration Ended

2024-512880-30-00 Neovascular Age-related Macular Degeneration (wet AMD) 5 2021-08-27
A Multicenter, Open-Label, Phase I/II Study of EOS884448 in combination with standard of care and/or investigational therapies in participan… Ended

2024-512227-36-00 Advanced solid tumors 9 2021-07-28
A study of GSK3511294 (Depemokimab) in participants who were previously enrolled in 206713 or 213744; Open-Label Extension Ended

2023-505203-23-01 Severe asthma with an eosinophilic phenotype 5 2021-07-26
A Multicenter, Randomized, Double Blind, Parallel Group Study to Assess the Efficacy and Safety of Oral Etrasimod as Induction and Maintenan… Ended

2024-513569-38-00 Crohn's Disease 10 2021-07-09
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy Ended

2023-510174-13-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2021-06-17
The efficacy and the safety of two doses of CHF6001 for the treatment of Chronic Obstructive Pulmonary Disease (COPD) Ended

2023-510175-60-00 Chronic obstructive pulmonary disease (COPD) and Chron 5 2021-06-16
HOPE study Ended

2024-516642-19-01 Acute Ischemic Stroke 6 2021-06-16
Non-inferiority study of GSK3511294 (depemokimab) compared with mepolizumab or benralizumab in participants with severe asthma with an eosin… Ended

2023-510230-84-00 Severe asthma with an eosinophilic phenotype 5 2021-05-28
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) Ended

2023-507977-16-00 Lupus Nephritis (LN) Immunoglobulin A Nephropathy (IgAN 4 2021-05-10
A randomized, 2-arm, open-label, phase II study of abemaciclib combined with endocrine therapy (letrozole or fulvestrant) with or without a … Ended

2023-509591-42-00 HR-positive/HER2-negative breast cancer 4 2021-05-04
Study to assess the efficacy, safety, and tolerability of SAR440340/REGN3500/itepekimab in chronic obstructive pulmonary disease (COPD) (AER… Ended

2024-512012-21-00 Chronic Obstructive Pulmonary Disease 5 2021-04-08